Log in
Register- BE study for Minoxidil jag009 2025-02-20 06:24 [Design Issues]
![[Mix]](https://static.bebac.at/img/mix.png "open in Mix view")
- FDA PSGs: Alternative approach Helmut 2025-02-20 10:44
- BE study for Minoxidil drgunasakaran1 2025-02-21 00:57
- BE study for Minoxidil jag009 2025-03-01 03:20
- BE study for Minoxidil ElMaestro 2025-03-01 20:29
- BE study for Minoxidil jag009 2025-03-01 03:20
- 2-period full replicate design for IR formulation – EMA perspective Ankit Parikh 2024-07-11 04:58 [Regulatives / Guidelines]
- 2-period full replicate design for IR formulation – EMA perspective BEQool 2025-03-01 12:33
- Question about Williams Design Bebac user 2025-02-25 20:30 [Design Issues]
- Significance The Outlaw Torn 2012-11-20 07:56 [Power / Sample Size]
- Significance ElMaestro 2012-11-20 08:17
- Significance The Outlaw Torn 2012-11-20 08:55
- Quality vs. Clinical ElMaestro 2012-11-20 09:04
- Significance The Outlaw Torn 2012-11-20 08:55
- Sample size? Helmut 2012-11-20 20:10
- Sample size? The Outlaw Torn 2012-11-21 07:52
- Sample size? The Outlaw Torn 2012-11-22 10:55
- Sample size, ratio, CV ↔ power Helmut 2012-11-22 13:35
- Sample size, ratio, CV ↔ power The Outlaw Torn 2012-11-23 14:47
- Sample size, ratio, CV ↔ power BEQool 2025-01-31 13:12
- TOST != treatment effect mittyri 2025-02-20 13:13
- Sample size, ratio, CV ↔ power zizou 2025-02-21 13:40
- Not vice versa mittyri 2025-02-22 21:08
- Not vice versa? zizou 2025-02-24 11:02
- Not vice versa? mittyri 2025-02-25 06:12
- Not vice versa? zizou 2025-02-24 11:02
- Not vice versa mittyri 2025-02-22 21:08
- Sample size, ratio, CV ↔ power Helmut 2012-11-22 13:35
- Sample size calculation using Marzo and Balant method kumarnaidu 2013-01-31 07:48
- Marzo / Balant formula d_labes 2013-01-31 10:05
- Marzo / Balant formula kumarnaidu 2013-01-31 10:54
- Marzo / Balant formula kumarnaidu 2013-02-04 05:48
- Marzo / Balant formula for parallel groups d_labes 2013-02-04 08:44
- Marzo / Balant formula kumarnaidu 2013-02-04 05:48
- Marzo / Balant formula kumarnaidu 2013-01-31 10:54
- Marzo / Balant formula d_labes 2013-01-31 10:05
- Significance ElMaestro 2012-11-20 08:17
- different ranks/levels of William design? Shuanghe 2025-02-12 00:46 [Design Issues]
- different ranks/levels of William design? BEQool 2025-02-19 11:34
- "ranking" William designs mittyri 2025-02-19 21:08
- "ranking" William designs vezz 2025-02-20 14:23
- "ranking" William designs Shuanghe 2025-02-23 11:47
- Product Labelling Query professionalr 2025-02-18 22:01 [Regulatives / Guidelines]
- Product Labelling Query drgunasakaran1 2025-02-18 23:38
- how to construct confidence interval for un-transformed metric? lizhao 2016-02-17 19:01 [Power / Sample Size]
- how to construct confidence interval for un-transformed metric? jag009 2016-02-17 20:43
- how to construct confidence interval for un-transformed metric? mittyri 2016-02-17 22:34
- Fieller’s confidence interval Helmut 2016-02-18 13:38
- Fieller’s confidence interval lizhao 2016-02-22 20:20
- Fieller’s confidence interval yjlee168 2016-02-23 08:23
- Rescue approaching – PowerTOST d_labes 2016-02-23 09:08
- Rescue approaching – PowerTOST Weidson 2024-11-28 23:15
- Why not base 🇷? Helmut 2024-12-03 13:39
- Why not base 🇷? Weidson 2025-02-15 20:42
- Why not base 🇷? Helmut 2024-12-03 13:39
- Rescue approaching – PowerTOST Weidson 2024-11-28 23:15
- Fieller’s confidence interval lizhao 2016-02-22 20:20
- Fieller’s confidence interval Helmut 2016-02-18 13:38
- Method A of EMA dshah 2025-02-10 07:27 [Software]
- ABEL: Why Excel? Helmut 2025-02-10 10:28
- ABEL: Why Excel? dshah 2025-02-10 15:40
- ABEL: Why Excel? Helmut 2025-02-10 10:28
- Bioequivalence studies for GCC submission professionalr 2025-01-30 23:00 [Design Issues]
- Bioequivalence studies for GCC submission drgunasakaran1 2025-01-31 03:20
- Conducting PK study in Mexico jag009 2025-01-28 20:13 [Regulatives / Guidelines]
- European Economic Area: ICH M13A effective with 25 January 2025 Helmut 2025-01-28 10:49 [Regulatives / Guidelines]
- Stratified randomisation in parallel BE studies and ANOVA model BEQool 2024-11-14 12:42 [Design Issues]
- Stratified randomisation in parallel BE studies BEQool 2025-01-27 08:03
- Compensation to patient Pharma_88 2025-01-22 13:02 [Regulatives / Guidelines]
- Compensation to patient drgunasakaran1 2025-01-23 00:52
- Compensation to patient NK 2025-01-24 04:39
- Tripolidine BE Study – Malaysian RLD professionalr 2025-01-21 22:19 [Design Issues]
- ASEAN BE Guideline Helmut 2025-01-22 11:40
- Issue with PBE Calculation when Stage = 1 weiguo2122 2025-01-13 20:19 [Regulatives / Guidelines]
- Issue with PBE Calculation when Stage = 1 ElMaestro 2025-01-13 21:08
- Issue with PBE Calculation when Stage = 1 weiguo2122 2025-01-15 20:45
- Issue with PBE Calculation when Stage = 1 ElMaestro 2025-01-13 21:08
Ing. Helmut Schütz